Patent · US Active

Salts of benzimidazolyl pyridyl ethers and formulations thereof

US8501785B2 · kind B2 · utility

0Cited by

3References

24Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Rampurna Gullapalli · San Bruno, US
Ahmad Hashash · Cambridge, US
Piotr H. Karpinski · Lincoln Park, US
Kangwen L. Lin · Fremont, US
Eric M. Loeser · North Plainfield, US
Augustus O. Okhamafe · Concord, US
Paul Allen Sutton · Parsippany, US
Eduardo Sy · Union City, US

Key dates

Filing date	Jun 4, 2012
Grant date	Aug 6, 2013
Priority date	—
Expiry date	Jun 4, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Salts of benzimidazolyl pyridyl ethers are provided, particularly salts of {1-methyl-5-[2-(5-trifluoromethyl-1H-imidazol-2-yl)-pyridin-4-yloxy]-1H-benzoimidazol-2-yl}-(4-trifluoromethyl-phenyl)amine. Compositions and formulations including such salts and surfactants as well as methods of preparing such compositions and formulations are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.